Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-097624
Filing Date
2025-10-07
Accepted
2025-10-07 19:13:50
Documents
2
Period of Report
2025-10-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2527674-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2527674-6_3seq1.xml 3 1683
2 EXHIBIT 24 tm2527674d6_ex24.htm EX-24 9154
  Complete submission text file 0001104659-25-097624.txt   12419
Mailing Address 250 N. WESTLAKE BLVD. #210 WESTLAKE VILLAGE CA 91362
Business Address 250 NORTH WESTLAKE BLVD. #210 WESTLAKE VILLAGE CA 91362 8185644011
Turn Therapeutics Inc. (Issuer) CIK: 0002023016 (see all company filings)

EIN.: 320456090 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 N. WESTLAKE BLVD STE 210 WESTLAKE VILLAGE CA 91362
Business Address
Chaudhary Zuraiz (Reporting) CIK: 0002086494 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42875 | Film No.: 251381012